Biogen soars 40% on hopes of Alzheimer's treatment approval, may be 'biggest drug ever,' says Cramer
October 22, 2019 at 10:09 AM EDT
Drug maker Biogen announced it is seeking regulatory approval for its Alzheimer's drug, months after it stopped testing the treatment.
